Analyst Ratings for Cytokinetics (CYTK)
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $146.00 (B.Riley)
- Lowest: $80.00 (Evercore ISI)
- Average: $105.42
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$105.42 (+70.2%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | William Blair | Alethia Young | New Coverage | Outperform (N/A) |
N/A (N/A) |
63.43 (61.95) |
-2.33% | Details |
| 6/29/2026 | UBS » Updated 10/14/2026 |
Ashwani Verma | Upgrade | Buy (Neutral) |
104.00 (115.00) |
80.80 (61.95) |
-23.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
